The Pharmaceutical Drug Delivery Market size was estimated to be US$ 1.74 billion in 2023 and is expected to reach US$ 3.15 billion by 2031; it is estimated to record a CAGR of 7.7% till 2031. Strategic developments and product launches are likely to remain key Pharmaceutical Drug Delivery Market trends.

Pharmaceutical Drug Delivery Market Analysis

Increasing geriatric population, increasing home healthcare, increasing prevalence of chronic diseases, increasing surgical procedures, and increasing prevalence of infectious diseases is driving the growth of the pharmaceutical drug delivery market. In addition, increase in FDA approval of various noninvasive drug delivery devices and increasing R&D expenditure by pharmaceutical companies for drug development has fueled the demand for pharmaceutical drug delivery.

Pharmaceutical Drug Delivery Market Overview

Drug delivery systems are primarily used for the controlled or targeted delivery of various therapeutic agents to treat various diseases or improve the health of the patients. China is one of the major emerging markets in pharmaceutical drug delivery market. The China drug delivery devices market is driven by the technological advancements in the medical device industry and the rise in focus on diagnosis and treatment of chronic diseases among the adults and the elderly population. China is expected to provide lucrative opportunities to local and international players to manufacture and market drug delivery devices in the country during the forecast period.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Get 10% FREE CUSTOMIZATION

Pharmaceutical Drug Delivery Market: Strategic Insights

Pharmaceutical Drug Delivery Market

• 
  CAGR (2023 - 2031)

  7.7%
• Market Size 2023
  US$ 1.74 billion
• Market Size 2031
  US$ 3.15 billion

Market Dynamics

GROWTH DRIVERS

• Increasing Prevalence of Chronic Diseases and Infectious Diseases
• Increasing Demand for Non-Invasive Drug Delivery

FUTURE TRENDS

• XXXXXXX
• XXXXXXX
• XXXXXXX

OPPORTUNITIES

• Focus on Improving Patient Compliance

Key Players

• Pfizer Inc.
• Bayer AG
• Johnson & Johnson Services, Inc.
• Novartis AG
• 3M
• BD
• Sanofi
• MERCK KGaA
• GlaxoSmithKline plc.
• Antares Pharma

Regional Overview

• North America
• Europe
• Asia-Pacific
• South and Central America
• Middle East and Africa

Market Segmentation

Route of Administration

• Oral Drug Delivery
• Injectable Drug Delivery
• Topical Drug Delivery
• Ocular Drug Delivery
• Pulmonary Drug Delivery
• Nasal Drug Delivery
• Transmucosal Drug Delivery
• Implantable Drug Delivery

Application

• Infectious Diseases
• Cancer
• Cardiovascular Diseases
• Diabetes
• Respiratory Diseases
• Central Nervous System Disorders
• Autoimmune Diseases
• Others

End User

• Hospitals
• Home Care Settings
• ASC and Clinics
• Others

Download Free Sample

   Buy Now   

• Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Pharmaceutical Drug Delivery Market Drivers and Opportunities

Increasing Demand for Non-Invasive Drug Delivery

Noninvasive drug delivery typically involves methods of painless drug delivery across the biological barriers of mucosal surfaces or skin. This drug delivery method could lead to enhanced access to medicines, improved drug safety profiles, and adherence to treatment regimes. Patients prefer noninvasive drug delivery routes due advantages over injection-based drug administration such as no injuries and infections due to needles, and cost effectiveness of noninvasive delivery routes. A few of the most popular noninvasive drug delivery methods are: Topical, transdermal-passive, transdermal-active (device-aided enhanced penetration), trans-mucosal membrane, trans-ocular membrane, and delivery via an alveolar membrane from inhaled medication. Drug delivery using noninvasive methods involves reduced dosing frequency and simplified dosing schedules. Moreover, these delivery systems can significantly reduce the cost of clinical use as patients can self-administer drugs via these methods. Thus, the growing demand for noninvasive drug delivery systems propels the growth of the drug delivery systems market.

Focus on Improving Patient Compliance – An Opportunity of Pharmaceutical Drug Delivery Market

Low patient compliance is a notable concern among physicians and medical device manufacturers. Hence, manufacturers are focusing on developing intuitive and user-friendly drug delivery systems that provide high patient comfort. Patients, caregivers, and physicians seek more patient-centric solutions, evaluating delivery systems and packaging options to encourage patients to take their medications as directed. Accurately measured doses and easy-to-use packaging with clear labeling are essential to meet today's self-sufficiency needs. A unit dose pack or container is filled precisely to contain medicines in quantities intended for a single dose. These features reduce medication errors because a drug's identity is quickly confirmed, and packaging ensures patients take the correct dose of medicines. Drug manufacturers are now focusing on drug delivery systems that offer ease of use, portability, and convenience for patients taking drugs at locations other than home. Patient compliance has been found to be much higher when drugs are administrated by noninvasive methods, as they experience decreased pain during the procedure.

Pharmaceutical Drug Delivery Market Report Segmentation Analysis

Key segments that contributed to the derivation of the Pharmaceutical Drug Delivery Market analysis are route of administration, application, and end user.

• Based on route of administration, the Pharmaceutical Drug Delivery Market is segmented into oral drug delivery, injectable drug delivery, topical drug delivery, ocular drug delivery, pulmonary drug delivery, nasal drug delivery, transmucosal drug delivery, and implantable drug delivery. The injectable drug delivery segment held the largest market share in 2023.
• By application, the Pharmaceutical Drug Delivery Market is segmented into infectious diseases, cancer, cardiovascular diseases, diabetes, respiratory diseases, central nervous system disorders, autoimmune diseases, and others. The cancer segment held the largest market share in 2023.
• Based on end user, the Pharmaceutical Drug Delivery Market is segmented into hospitals, home care settings, ASCs and clinics, and others. The hospitals segment held the largest market share in 2023.

Pharmaceutical Drug Delivery Market Share Analysis by Geography

The geographic scope of the Pharmaceutical Drug Delivery Market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America.

North America has dominated the Pharmaceutical Drug Delivery Market. The market growth in North America is characterized by increased demand for infectious disease medications from patient, the presence of key market players, an increase in product launches, increasing prevalence of chronic diseases, and extensive R&D conducted by academic and research institutes and pharmaceutical. Due to technological advancements, infusion therapies can be safely and effectively managed at home. Infusion therapy in homecare settings has evolved into a completely cost-effective therapy, and it has resulted in the creation of inpatient treatment in a hospital or skilled nursing facility, thereby driving the growth of drug delivery market in North America. Moreover, Asia Pacific is anticipated to record the highest CAGR in the coming years. 

Pharmaceutical Drug Delivery Market Report Scope

Download Free Sample

   Buy Now   

• Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Pharmaceutical Drug Delivery Market News and Recent Developments

The Pharmaceutical Drug Delivery Market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the market for pharmaceutical drug delivery and strategies:

• Stevanato Group collaborated with Recipharm to develop and manufacture pre-fillable syringes that would be integrated into a new soft mist inhaler for inhaling sensitive biological products. The new strategic collaboration aims to provide innovative primary packaging to pharmaceutical and biopharmaceutical companies using Recipharm’s proprietary soft mist inhalers. (Source: Stevanato Group, Company Website, 2023)
• Coherus BioSciences, Inc has launched its UDENYCA on-body injector (OBI) utilizing the LTS Sorrel wearable drug delivery platform. UDENYCA (pegfilgrastim-cbqv) is a biosimilar pegfilgrastim administered the day after chemotherapy to decrease the incidence of infection as manifested by febrile neutropenia.  (Source: Cision US Ltd, Press Release, 2024)

Pharmaceutical Drug Delivery Market Report Coverage and Deliverables

The “Pharmaceutical Drug Delivery Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:

• Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
• Market dynamics such as drivers, restraints, and key opportunities
• Key future trends
• Detailed PEST/Porter’s Five Forces and SWOT analysis
• Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
• Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments
• Detailed company profiles